News und Analysen
Eilt: Krebs vollständig geheilt - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Krebs vollständig geheilt - Massives Kaufsignal. 202% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
26.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Kimberly-Clark Raises Sales and Profit Guidance, Can it Breakout?
In May 2023, Kimberly-Clark Corporation (NYSE: KMB) stock climbed to a 52-week high of $147.87. However, the stock has failed to hold those gains and heading into the company’s earnings report, KMB
Energy Stocks Bullish, But Futures Market Signals Trouble Ahead
The Energy Select Sector SPDR Fund (NYSEARCA: XLE) was trading higher for the fifth session in a row on July 24, extending that streak with a gap up at the open.
However, some analysts are
Will Cloudflare Go Back Into Rally Mode After Q2 Earnings Report?
The recent rally in erstwhile tech leader Cloudflare Inc. (NYSE: NET) is a good reminder of why it’s important to stay up to speed on sector rotation, as it can have a big impact on your overall
Will Q2 Earnings Propel Payment Processor Shift4?
Payment processing specialist Shift4 Payments Inc. (NYSE: FOUR) formed a bullish base below resistance at $76.40. Its second-quarter earnings report on August 3 is a possible catalyst for a
It's Not a Stretch to Say Under Armour Stock Has Bottomed
When Under Armour, Inc. (NYSE: UAA) reports quarterly results next week, Wall Street won’t be expecting much — and that’s a good thing.
Analysts project that the athletic clothing manufacturer will
Sensation: Vollständige Krebsheilung - Massives Kaufsignal. Neuer 202% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensation: Vollständige Krebsheilung - Massives Kaufsignal. 202% Biotech Aktientip nach 15.973% mit BioNTech ($BNTX)
25.07.23 08:02
London (www.aktiencheck.de, Anzeige)
Rivian: A Roaring Rise Or Time To Cash Out?
Since breaking out over critical resistance at $16, shares of Rivian Automotive (NASDAQ: RIVN) haven’t looked back. The stock is up almost 87% in the last month and 106% over the previous three
Is Ryanair Overbought? Earnings Say Not Likely
A word of warning for investors holding shares in Ryanair (NASDAQ: RYAAY), with high potential upside, comes high potential volatility. Shares of the European airline are down by as much as 9.6%
Sirius-ly? Sirius XM Stock Squeezes 40% in 3 Hours
The Liquid Metal and Octane hard rock stations aren’t the only things making noise at Sirius XM Holdings Inc. (NASDAQ:SIRI) these days.
On Thursday, shares of the nation’s top satellite radio
AI Over? Is Slowdown in ChatGPT Traffic a Sign of AI Fatigue?
2023 will be remembered as the breakout year for artificial intelligence (AI), with credit given to the explosive viral growth of ChatGPT. The ChatGPT broke records when it surpassed over 100
3 Consumer Discretionary Stocks That Still Have Pricing Power
What’s one of the best predictors of stock price performance? If you said earnings growth, you’re right. But what is a reliable indicator of earnings growth? That would be pricing power. A common
5 Reasons Alibaba Stock Under $100 is a Generational Opportunity
Could this be the last year that Alibaba Group Holding Limited (NYSE:BABA) trades below $100 per share?
China’s e-commerce leader sits more than 70% below its October 2020 peak. Albeit during the
Ross Stores Fashioning Growth: Analysts See Double-Digit EPS Rise
Ross Stores Inc. (NASDAQ: ROST) is trading higher for the week, following news that the company is opening new locations at a fast pace and is on track to add about 100 new stores during fiscal
Krebs erfolgreich geheilt - Klinische Studie mit sensationellen Ergebnissen. Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
Krebs erfolgreich geheilt - Klinische Studie mit sensation. Ergebnissen. 202% Biotech Hot Stock nach 134.452% mit Biogen
24.07.23 08:02
London (www.aktiencheck.de , Anzeige)
ISRG Stock Sinks After Strong Earnings: Is the Growth Priced In?
Timing is everything. Intuitive Surgical, Inc. (NASDAQ: ISRG) delighted investors by beating revenue and earnings expectations when it reported second-quarter earnings after the market closed on
Winners And Losers In The Oilfield Supercycle
There are no losers in the oil field super cycle, only winners, but winning is relative. While the signs are good that the spending in upstream, natural gas, and efficiency will continue, 1
Joby Downgraded: Is This The Buying Opportunity We’ve Wanted?
Our regular readers will be well familiar with Joby Aviation Inc (NYSE: JOBY), whose massive potential we first wrote about last November. We flagged fresh upside potential in late February and
Did CSX Corporation’s Rebound Just Go Off The Rails?
CSX Corporation (NASDAQ: CSX) stock has been trying hard to get off a technical bottom, and the recovery might have gone off the rails. The Q2 results were less than expected and caused shares
IBM Is The Perfect Example Of Why Size Matters: An Earnings Story
International Business Machines (NYSE: IBM) share rose by as much as 3.0% to mark the high for Thursday's trading session. The reaction came from the company's second quarter 2023 earnings
2 Fintech Stocks to Buy Now and 1 to Avoid
Youth will be served. That’s how I would explain the speed and pervasiveness with which financial technology (fintech) has disrupted the financial sector. Millennial and Gen-Z investors have grown
Biotech Hot Stock meldet großartige Studienergebnisse - Massives Kaufsignal. Neuer 202% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB).
Biotech Hot Stock meldet großartige Studienergebnisse - Kaufsignal. 202% Biotech Aktientip nach 10996% mit Pfizer ($PFE)
21.07.23 08:02
London (www.aktiencheck.de , Anzeige)
U.S. Bancorp Shares Rally As Analysts Get Bullish After Q2 Report
Analysts have been vocal lately about U.S. Bancorp’s (NYSE: USB) potential, emphasizing that shares have been undervalued as investors focused on requirements for capital holdings.
U.S. Bancorp
American Airlines Beats Earnings, Thinking Of Buying?
Airline giant American Airlines Group (NASDAQ: AAL) reported second-quarter 2023 earnings results. The stock is trading down 6% in early trading as investors digest the report, perhaps providing
3 Undervalued Large-Cap Stocks That Won't Be for Long
The market rally is starting to extend beyond the “Magnificent 7” tech stocks. Yet many analysts and economists still believe investors may be in for a nasty pullback before the year ends.
Market